Oramed Pharmaceuticals (ORMP) Operating Leases (2019 - 2026)
Oramed Pharmaceuticals (ORMP) reported Operating Leases of $493000.0 for Q1 2026, up 310.83% on a YoY basis from $120000.0 in Q1 2025, and down 8.7% quarter-over-quarter from $540000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Operating Leases (2019 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Operating Leases for 8 years, with the latest figure at $493000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 310.83% year-over-year to $493000.0; the trailing twelve-month figure through Mar 2026 stood at $493000.0 (up 310.83% YoY), and the FY2025 full-year result was $540000.0, up 246.15% from the prior year.
- Operating Leases for Q1 2026 stood at $493000.0, down from $540000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.1 million in Q1 2022, with the low at $120000.0 in Q1 2025.
- Historically, Operating Leases has averaged $495705.9 across 5 years, with a median of $493000.0 in 2026.
- Annual changes were most pronounced in 2025 — Operating Leases slumped 55.88% — and 2026, when it surged 310.83%.
- Oramed Pharmaceuticals' Operating Leases stood at $647000.0 in 2022, then sank by 47.14% to $342000.0 in 2023, then plunged by 54.39% to $156000.0 in 2024, then soared by 246.15% to $540000.0 in 2025, then retreated by 8.7% to $493000.0 in 2026.
- The last three Operating Leases figures came in at $493000.0 (Q1 2026), $540000.0 (Q4 2025), and $589000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 493,000.00 |
| Dec 31, 2025 | 540,000.00 |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | 648,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 236,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 342,000.00 |
| Sep 30, 2023 | 389,000.00 |
| Jun 30, 2023 | 488,000.00 |
| Mar 31, 2023 | 564,000.00 |
| Dec 31, 2022 | 647,000.00 |
| Sep 30, 2022 | 672,000.00 |
| Jun 30, 2022 | 977,000.00 |
| Mar 31, 2022 | 1.11 Mn |
| Nov 30, 2021 | 374,000.00 |
| Aug 31, 2021 | 403,000.00 |
| May 31, 2021 | 431,000.00 |